# OPTimizing Treatment Focused Genetic Testing IN Cancer

> **NCT04066361** · NA · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 301 (actual)

## Conditions studied

- Breast Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer

## Interventions

- **OTHER:** Chatbot
- **OTHER:** Video Education

## Key facts

- **NCT ID:** NCT04066361
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-19
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 301 (ACTUAL)
- **Last updated:** 2024-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04066361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04066361, "OPTimizing Treatment Focused Genetic Testing IN Cancer". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04066361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*